Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition

• Main Authors: Nina R. Sperber (Author), Megan C. Roberts (Author), Sarah Gonzales (Author), Lisa M. Bendz (Author), Deborah Cragun (Author), Susanne B. Haga (Author), R. Ryanne Wu (Author), Chioma Omeogu (Author), Brystana Kaufman (Author), Natasha J. Petry (Author), Laura B. Ramsey (Author), Ryley Uber (Author)
• Format: Book
• Published: Wiley, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Pharmacogenetic testing could reduce the time to identify a safe and effective medication for depression; however, it is underutilized in practice. Major depression constitutes the most common mental disorder in the US, and while antidepressant therapy can help, the current trial -and error...